Basic science of cystic fibrosis

Current Paediatrics

Volumn 13, Issue 4, 2003, Pages 253-258

  Hull, Jeremy ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Diagnosis; Genetics; Genotype; Phenotype pathogenesis

Indexed keywords

CHLORIDE; DNA; ELASTASE; GENE PRODUCT; MESSENGER RNA; NITRIC OXIDE; SODIUM; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CHLORIDE TRANSPORT; CHROMOSOME 7; CONFERENCE PAPER; CYSTIC FIBROSIS; EXHALATION; FECES ANALYSIS; GENE MUTATION; GENETIC DISORDER; GENOTYPE; HUMAN; LUNG DISEASE; MORBIDITY; MORTALITY; PATHOGENESIS; PHENOTYPE; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; SODIUM TRANSPORT; SPUTUM CULTURE; SWEAT TEST;

EID: 0037635437     PISSN: 09575839     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-5839(03)00029-0     Document Type: Conference Paper

References (30)

1. Rommens J M, Iannuzzi M C, Kerem B et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059-1065.
2. Doull I J. Recent advances in cystic fibrosis. Arch Dis Child 2001; 85: 62-66.
3. Boucher R C. An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev 2002; 54: 1359-1371.
4. Rosenstein B J, Zeitlin P L. Cystic fibrosis. Lancet 1998; 351: 277-282.
5. Salvatore F, Scudiero O, Castaldo G. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet 2002; 111: 88-95.
6. Jaffe A, Bush A, Geddes D M, Alton E W. Prospects for gene therapy in cystic fibrosis. Arch Dis Child 1999; 80: 286-289.
7. Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 2000; 67: 117-133.
8. Trezise A E, Chambers J A, Wardle C J, Gould S, Harris A. Expression of the cystic fibrosis gene in human foetal tissues. Hum Mol Genet 1993; 2: 213-218.
9. Broackes-Carter F C, Mouchel N, Gill D, Hyde S, Bassett J, Harris A. Temporal regulation of CFTR expression during ovine lung development: implications for CF gene therapy. Hum Mol Genet 2002; 11: 125-131.
10. Hogenauer C, Santa Ana C A, Porter J L et al. Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am J Hum Genet 2000; 67: 1422-1427.
11. Chu C S, Trapnell B C, Curristin S, Cutting G R, Crystal R G. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993; 3: 151-156.
12. Durno C, Corey M, Zielenski J, Tullis E, Tsui L C, Durie P. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2002; 123: 1857-1864.
13. Correlation between genotype and phenotype in patients with cystic fibrosis. The Cystic Fibrosis Genotype-Phenotype Consortium. N Engl J Med 1993; 329: 1308-1313.
14. Hull J, Thomson A H. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 1998; 53: 1018-1021.
15. Knowles M R, Konstan M W, Handler A et al. Multi-center study of gene modifiers for CF lung disease: clinical phenotype of homozygous patients (deltaF/deltaF) with "mild" versus "severe" lung disease. Pediatr Pulmonol 2002; 24 (Suppl.): 222.
16. Rigot J M, Lafitte J J, Dumur V et al. Cystic fibrosis and congenital absence of the vas deferens. N Engl J Med 1991; 325: 64-65.
17. Pignatti P F, Bombieri C, Marigo C, Benetazzo M, Luisetti M. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet 1995; 4: 635-639.
18. Sharer N, Schwarz M, Malone G et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998; 339: 645-652.
19. Burch L H, Talbot C R, Knowles M R, Canessa C M, Rossier B C, Boucher R C. Relative expression of the human epithelial Na+ channel subunits in normal and cystic fibrosis airways. Am J Physiol 1995; 269: C511-C518.
20. Khan T Z, Wagener J S, Bost T, Martinez J, Accurso F J, Riches D W. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151: 1075-1082.
21. Zahm J M, Gaillard D, Dupuit F et al. Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice. Am J Physiol 1997; 272: C853-C859.
22. van den Hoogen B G, de Jong J C, Groen J et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7: 719-724.
23. Dakin C J, Numa A H, Wang H, Morton J R, Vertzyas C C, Henry R L. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 2002; 165: 904-910.
24. Smith J J, Travis S M, Greenberg E P, Welsh M J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996; 85: 229-236.
25. Hull J, Skinner W, Robertson C, Phelan P. Elemental content of airway surface liquid from infants with cystic fibrosis. Am J Respir Crit Care Med 1998; 157: 10-14.
26. Knowles M R, Robinson J M, Wood R E et al. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J Clin Invest 1997; 100: 2588-2595.
27. Tarran R, Grubb B R, Parsons D et al. The CF salt controversy: in vivo observations and therapeutic approaches. Mol Cell 2001; 8: 149-158.
28. Matsui H, Grubb B R, Tarran R et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998; 95: 1005-1015.
29. Walkowiak J, Herzig K H, Strzykala K, Przyslawski J, Krawczynski M. Fecal elastase-I is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics 2002; 110: e7.
30. Narang I, Ersu R, Wilson N M, Bush A. Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax 2002; 57: 586-589.